CHLORPROPAMIDE

Chlorpropamide is a sulfonylurea stimulating insulin release to manage type 2 diabetes. Side effects include hypoglycemia, flushing, and hyponatremia.

SKU: d15cd8c7a450 Category: Tag:

Product Description


Mechanism of Action

Chlorpropamide is a first-generation sulfonylurea that stimulates insulin release from pancreatic β-cells. It binds to the SUR1 subunit of ATP-sensitive potassium (K_ATP) channels, causing closure of the channel, membrane depolarisation, opening of voltage-dependent calcium channels and insulin granule exocytosis. It has a long half-life, producing prolonged hypoglycaemic effects.

Benefits and Advantages

Used in diabetes-pathway modelling, K_ATP channel studies, β-cell physiology research, sulfonylurea SAR investigations, insulin-secretion assays and historical oral hypoglycaemic compound comparisons.

Side Effects and Risks

Risks include prolonged hypoglycaemia, flushing (especially with alcohol), water retention, hyponatraemia (SIADH), weight gain and allergic reactions. Handle with glucose-lowering agent precautions.

Datasheet


Molecular Formula

C10H13ClN2O3S

Molecular Weight

276.74 g/mol

CAS Number

94-20-2

Storage Condition

Store in a cool, dry place. Keep container tightly closed. Protect from moisture and light.

Solubility

less than 1 mg/mL at 57 °F (NTP, 1992)

Purity

Purity information is available upon request (COA).

Synonym

chlorpropamide; 94-20-2; Diabinese; Glucamide; Diabenese

IUPAC/Chemical Name

1-(4-chlorophenyl)sulfonyl-3-propylurea

InChl Key

RKWGIWYCVPQPMF-UHFFFAOYSA-N

InChl Code

InChI=1S/C10H13ClN2O3S/c1-2-7-12-10(14)13-17(15,16)9-5-3-8(11)4-6-9/h3-6H,2,7H2,1H3,(H2,12,13,14)

References

https://pubchem.ncbi.nlm.nih.gov/compound/2727;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download